Literature DB >> 11094995

Indwelling catheters for the management of malignant ascites.

A Lee1, T N Lau, K Y Yeong.   

Abstract

Paracentesis is widely employed for palliation of symptomatic malignant ascites. In some patients, there is rapid re-accumulation of fluid necessitating frequent repeat procedures. Indwelling peritoneal drainage catheters can provide more durable symptom relief, avoiding the hazards and disadvantages of multiple repeat procedures. The goal of our study was to evaluate the technical success, complications and outcome associated with the use of these drainage catheters. We carried out a retrospective review of all patients who had indwelling catheters inserted for the management of symptomatic malignant ascites over a 4-year period. A total of 45 catheters were inserted in 38 patients. Insertion was technically successful in all patients, with immediate symptomatic relief. However, 2 cases of fatal hypotension were encountered in the first 24 h after catheter insertion (acute catheter-related mortality rate of 4.4%). These were attributed to rapid drainage of peritoneal fluid, although gastrointestinal tract bleeding was contributory in the second patient. Eight patients were lost to follow-up. Of the remaining 30, 13 (35.1%) patients developed catheter-related sepsis. The rate of infection was 1.6 episodes per 100 catheter-days. Thirteen tubes were removed prematurely, 6 (16.2%) due to sepsis, 5 (13.5%) because of tube blockage and 2 (5.4%) because of loculated ascites. The median length of time for which catheters were functional was 37 days (95% CI 14.1-59.6), with an average daily drainage of 539.5 ml (range 18-4000 ml). In conclusion, indwelling peritoneal drainage catheters provide a useful alternative to paracentesis in the management of symptomatic malignant ascites. Although it avoids the need for repeated paracentesis, it is not without risks. We discuss and propose some precautions to be observed in the use of these catheters.

Entities:  

Mesh:

Year:  2000        PMID: 11094995     DOI: 10.1007/s005200000139

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  16 in total

Review 1.  Permanent catheters for recurrent ascites-a critical and systematic review of study methodology.

Authors:  Lars Christensen; Lorna Wildgaard; Kim Wildgaard
Journal:  Support Care Cancer       Date:  2016-03-01       Impact factor: 3.603

2.  PleurX drain use in the management of malignant ascites: safety, complications, long-term patency and factors predictive of success.

Authors:  C R Tapping; L Ling; A Razack
Journal:  Br J Radiol       Date:  2011-03-22       Impact factor: 3.039

3.  Percutaneous management of malignant fluid collections.

Authors:  Leann S Stokes
Journal:  Semin Intervent Radiol       Date:  2007-12       Impact factor: 1.513

Review 4.  Chronic peritoneal indwelling catheters for the management of malignant and nonmalignant ascites.

Authors:  Joseph Caldwell; Hawa Edriss; Kenneth Nugent
Journal:  Proc (Bayl Univ Med Cent)       Date:  2018-06-01

5.  Peritoneal catheter for massive cardiac ascites.

Authors:  Gabriel M Aisenberg
Journal:  BMJ Case Rep       Date:  2013-04-16

6.  Peritoneal catheter for continuous drainage of ascites in advanced cancer patients.

Authors:  Sebastiano Mercadante; Giuseppe Intravaia; Patrizia Ferrera; Patrizia Villari; Fabrizio David
Journal:  Support Care Cancer       Date:  2008-05-01       Impact factor: 3.603

Review 7.  Treatment of malignant ascites.

Authors:  Michael Chung; Peter Kozuch
Journal:  Curr Treat Options Oncol       Date:  2008-09-06

8.  Feasibility of externalized peritoneovenous shunt (EPVS) for malignant ascites.

Authors:  Hiroyuki Tokue; Yoshito Takeuchi; Yasuaki Arai; Keitaro Sofue; Noriaki Sakamoto; Yoshito Tsushima; Keigo Endo
Journal:  World J Surg Oncol       Date:  2011-07-21       Impact factor: 2.754

Review 9.  Peritoneal Dialysis Use in Patients With Ascites: A Review.

Authors:  Nilum Rajora; Lucia De Gregorio; Ramesh Saxena
Journal:  Am J Kidney Dis       Date:  2021-06-16       Impact factor: 8.860

10.  Chryseobacterium indologenes peritonitis in a patient with malignant ascites.

Authors:  Yung-Chih Wang; Kuo-Ming Yeh; Sheng-Kang Chiu; Shih-Ta Shang; Li-Ping Kan; Ching-Mei Yu; Jung-Chung Lin
Journal:  Int Med Case Rep J       Date:  2011-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.